Letter comments on: Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma

Eur J Cancer. 2024 Jul:205:114097. doi: 10.1016/j.ejca.2024.114097. Epub 2024 May 7.

¹ Medical Oncology Unit, Ospedale San Paolo, Savona, Italy; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova, Italy. Electronic address: saraelena89@hotmail.it.
² Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
³ Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth PO6 3LY, United Kingdom; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2UP, United Kingdom.
⁴ Translationsal and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle Upon Tyne, United Kingdom; Candiolo Cancer Institute, FPO-IRCCS, Turin, Candiolo, Italy.
⁵ Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy.

No abstract available

Publication types